Valuation: iCAD Inc

Market Cap 106M 91.5M 86.35M 78.33M 147M 10.12B 148M 1.03B 397M 5.13B 397M 388M 16.32B P/E 2023
-9.35x
P/E 2024 -8.59x
Enterprise Value 88.75M 76.9M 72.57M 65.84M 124M 8.51B 124M 867M 334M 4.32B 333M 326M 13.72B EV / Sales 2023
1.47x
EV / Sales 2024 1.6x
Free-Float
99.32%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 61 10/03/2023
Director of Finance/CFO 54 17/07/2025
Corporate Secretary - 17/07/2025
Change 5-day change 1-year change 3-year change Capi.($)
+2.34%+4.11%+32.32%+21.78% 227B
+1.21%+0.33%+9.21%-19.33% 143B
-2.31%+5.78%-14.65%+25.33% 134B
-2.57%-2.31%-56.00%-16.94% 65.29B
+0.17%+0.41%-18.09%-15.11% 50.09B
-0.15%-1.70%+12.09%+16.45% 49.29B
+1.20%+1.50%+18.64%+28.59% 41.39B
+1.41%+3.36%+39.26%+50.99% 40.28B
+2.35%+3.67%-15.50%+57.61% 31.9B
Average +0.39%-1.73%+0.81%+16.60% 86.84B
Weighted average by Cap. +0.48%-0.91%+5.86%+12.26%

Financials

2023 2024
Net sales 17.32M 15.01M 14.16M 12.85M 24.1M 1.66B 24.27M 169M 65.17M 842M 65.04M 63.61M 2.68B 19.61M 16.99M 16.03M 14.55M 27.29M 1.88B 27.48M 191M 73.79M 953M 73.65M 72.02M 3.03B
Net income -4.85M -4.2M -3.96M -3.6M -6.75M -465M -6.79M -47.34M -18.24M -236M -18.2M -17.8M -749M -5.62M -4.87M -4.59M -4.17M -7.82M -538M -7.87M -54.85M -21.13M -273M -21.09M -20.63M -868M
Net Debt -21.21M -18.38M -17.34M -15.73M -29.51M -2.03B -29.73M -207M -79.81M -1.03B -79.66M -77.9M -3.28B -16.84M -14.6M -13.77M -12.5M -23.44M -1.61B -23.61M -164M -63.39M -819M -63.26M -61.87M -2.6B
Logo iCAD Inc
iCAD Inc is a United States‑based company. The Company develops artificial intelligence solutions designed to support healthcare providers in the detection and diagnosis of cancer. The company focuses on providing clinically proven AI technologies that assist medical professionals in identifying cancer earlier, improving diagnostic accuracy, and enhancing workflow efficiency. Its solutions include platforms for cancer detection, breast density assessment, and risk evaluation, enabling clinicians to analyze medical images and support patient care decisions. The company leverages advanced data, clinical evidence, and AI‑driven technologies to deliver tools that integrate into existing healthcare systems and assist in screening and diagnostic processes across global markets.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!